Cargando…

PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models

BACKGROUND: Cancer cells have developed molecular strategies to cope with evolutionary stressors in the dynamic tumor microenvironment. Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) is a metabolic rheostat that regulates diverse cellular adaptive behaviors, including growth and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Ki Cheong, Kim, Jung Min, Kim, Sang Yong, Kim, Seok-Mo, Lim, Jin Hong, Kim, Min Ki, Fang, Sungsoon, Kim, Yonjung, Mills, Gordon B., Noh, Sung Hoon, Cheong, Jae-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893610/ https://www.ncbi.nlm.nih.gov/pubmed/36726166 http://dx.doi.org/10.1186/s12916-023-02727-8

Ejemplares similares

Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer
por: Yun, Hyeok Jun, et al.
Publicado: (2022)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
por: Kim, Soo Young, et al.
Publicado: (2018)

Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
por: Chang, Hang-Seok, et al.
Publicado: (2023)

The Role of TRP Channels and PMCA in Brain Disorders: Intracellular Calcium and pH Homeostasis
por: Hwang, Sung-Min, et al.
Publicado: (2021)

Discovery of Pharmaceutical Composition for Prevention and Treatment in Patient-Derived Metastatic Medullary Thyroid Carcinoma Model
por: Yun, Hyeok-Jun, et al.
Publicado: (2022)

Three-year outcomes of vitrectomy combined with intraoperative dexamethasone implantation for non-tractional refractory diabetic macular edema
por: Hwang, Sungsoon, et al.
Publicado: (2021)

Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis
por: Lim, Jin Hong, et al.
Publicado: (2020)

Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer
por: Hwang, Nahee, et al.
Publicado: (2023)

Current Management and Future Strategies of Gastric Cancer
por: Lee, Joong Ho, et al.
Publicado: (2012)

Adenocarcinoma derived from gastric hamartomatous polyps
por: Oh, Seung Jong, et al.
Publicado: (2011)

Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma
por: Lim, Jin Hong, et al.
Publicado: (2022)

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models
por: Yun, Hyeok Jun, et al.
Publicado: (2021)

Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer
por: Kim, Seok-Mo, et al.
Publicado: (2020)

Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells()()
por: Lee, Yong Sang, et al.
Publicado: (2018)

Methylene Blue Blocks and Reverses the Inhibitory Effect of Tau on PMCA Function
por: Berrocal, Maria, et al.
Publicado: (2019)

Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer
por: Kim, Yuna, et al.
Publicado: (2023)

Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer
por: Kim, Seok-Mo, et al.
Publicado: (2015)

Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer
por: Kim, Jun Yong, et al.
Publicado: (2023)

Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer
por: Park, Ki Cheong, et al.
Publicado: (2017)

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153]
por: Park, Ki Cheong, et al.
Publicado: (2017)

Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea
por: Kim, Hyo Jung, et al.
Publicado: (2015)

Clinical Variables Correlated with Numbers of Intra-arterial Nimodipine Infusion in Patients with Medically Refractory Cerebral Vasospasm
por: Kim, Sang-Young, et al.
Publicado: (2015)

Solitary lateral neck node metastasis in papillary thyroid carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2014)

Topical Methyl Aminolevulinate Photodynamic Therapy in Porokeratosis of Mibelli: An Alternative Treatment for a Refractory Disease
por: Cho, Yeo-Rye, et al.
Publicado: (2019)

Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second
por: Kim, Jin-Hyo, et al.
Publicado: (2022)

CDX-1/CDX-2 Expression Is a Favorable Prognostic Factor in Epstein-Barr Virus-Negative, Mismatch Repair-Proficient Advanced Gastric Cancers
por: Kim, Kyeongmin, et al.
Publicado: (2021)

Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
por: An, Ji Yeong, et al.
Publicado: (2013)

Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer
por: Choi, Yoon Young, et al.
Publicado: (2016)

Role of NCKAP1 in the Defective Phagocytic Function of Microglia-Like Cells Derived from Rapidly Progressing Sporadic ALS
por: Noh, Min-Young, et al.
Publicado: (2023)

Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD
por: Baek, Dong Won, et al.
Publicado: (2022)

Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience
por: Jeon, Young‐Woo, et al.
Publicado: (2019)

The Establishment of Dendritic Cell-Tumor Fusion Vaccines for Hormone Refractory Prostate Cancer Cell
por: Kim, Tae-Beom, et al.
Publicado: (2010)

Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2022)

Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer: Results from two large Korean cohorts
por: Choi, Yoon Young, et al.
Publicado: (2021)

Plasma Membrane Ca(2+) Pump PMCA4z Is More Active Than Splicing Variant PMCA4x
por: Corradi, Gerardo R., et al.
Publicado: (2021)

Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments
por: Kim, Kyung-Min, et al.
Publicado: (2016)

Changes in Treatment Outcomes of Gastric Cancer Surgery Over 45 Years at A Single Institution
por: Hyung, Woo Jin, et al.
Publicado: (2008)

Blood culture contamination in hospitalized pediatric patients: a single institution experience
por: Min, Hyewon, et al.
Publicado: (2014)

PPARγ Targets-Derived Diagnostic and Prognostic Index for Papillary Thyroid Cancer
por: Kim, Jaehyung, et al.
Publicado: (2021)

Oncologic Safety of Laparoscopic Wedge Resection with Gastrotomy for Gastric Gastrointestinal Stromal Tumor: Comparison with Conventional Laparoscopic Wedge Resection
por: Lee, Sejin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hgpk86q4qu18vj32tqoek2decq